iRhythm Technologies (NASDAQ: IRTC) reported Q1 EPS of ($0.47), $0.11 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $30.6 million versus the consensus estimate of $29.06 million.

Guidance for Full Year 2018

iRhythm projects revenue for the full year 2018 to range from $128.5 to $133.5 million, inclusive of ASC 606, which represents 36-41% growth over the company’s prior year, as adjusted and presented on a non-GAAP basis to show the effects of ASC 606. Gross margins for the full year 2018 are expected to range from 71.5% to 72.5% and operating expenses for the full year 2018 to be between $127 and $132 million. This compares to previous revenue guidance of $126 to $131 million, inclusive of ASC 606; gross margins of 70% to 72% and operating expenses of $124 to $129 million.

For earnings history and earnings-related data on iRhythm Technologies (IRTC) click here.